Copyright
©The Author(s) 2023.
World J Diabetes. Aug 15, 2023; 14(8): 1271-1279
Published online Aug 15, 2023. doi: 10.4239/wjd.v14.i8.1271
Published online Aug 15, 2023. doi: 10.4239/wjd.v14.i8.1271
Group | Number of cases | BFGF (g/L) | |||
Prior treatment | One month of treatment | Three months of treatment | Treatment for 6 mo | ||
Control group | 65 | 52.16 ± 8.17 | 49.31 ± 7.281 | 40.21 ± 6.221,2 | 32.41 ± 3.211,2,3 |
Observation group | 65 | 53.07 ± 8.02 | 44.12 ± 7.161 | 33.34 ± 5.981,2 | 23.62 ± 3.161,2,3 |
t value | -0.201 | 3.675 | 6.601 | 11.661 | |
P value | 0.841 | < 0.001 | < 0.001 | < 0.001 |
- Citation: Zhan HQ, Zhou JL, Zhang J, Wu D, Gu CY. Conbercept combined with laser photocoagulation in the treatment of diabetic macular edema and its influence on intraocular cytokines. World J Diabetes 2023; 14(8): 1271-1279
- URL: https://www.wjgnet.com/1948-9358/full/v14/i8/1271.htm
- DOI: https://dx.doi.org/10.4239/wjd.v14.i8.1271